The Scotts Miracle-Gro (SMG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
29 Dec, 2025Executive summary
Achieved robust gross margin and EPS growth in fiscal 2025, with strong U.S. Consumer sales, significant free cash flow, and improved profitability, supported by supply chain optimization and operational efficiencies.
Deepened competitive moat through brand strength, R&D, supply chain, and sales execution, gaining market share in a growing consumer category.
Continued debt reduction, lowering leverage ratio to 4.1x and interest expense by $30 million.
Retail partnerships remained robust, with increased predictability and financial flexibility; new credit facility expected on better terms.
Proposed multi-year share buyback program for fiscal 2026, emphasizing shareholder returns beyond dividends.
Financial highlights
Full-year company sales reached $3.41 billion; U.S. Consumer net sales were $2.99 billion, with adjusted EBITDA at $581 million, up 14% year-over-year.
Gross margin improved by 490 basis points to 31.2% (non-GAAP), exceeding the 30% target.
Free cash flow was $274 million, surpassing targets and used for debt reduction and dividends.
GAAP net income for the year was $145.2 million ($2.47/share); non-GAAP adjusted EPS was $3.74, up 63% year-over-year.
Q4 2025 net sales were $387.4 million, down 7% from Q4 2024; adjusted net loss improved to $(113.1) million.
Outlook and guidance
Fiscal 2026 guidance: low single-digit U.S. Consumer net sales growth, non-GAAP gross margin of at least 32%, adjusted EPS of $4.15–$4.35, and free cash flow of $275 million.
Leverage ratio expected to fall into the high threes by end of FY26 and below 3.5x by FY27; mid-single-digit adjusted EBITDA growth anticipated.
Focus on branded product growth, e-commerce expansion, innovation, and continued cost savings and automation.
Latest events from The Scotts Miracle-Gro
- Hawthorne divestiture, margin gains, and share buyback support improved outlook.SMG
Q1 20264 Feb 2026 - Margin expansion, $150M supply chain savings, and 3% sales growth drive future value.SMG
Investor Day 20243 Feb 2026 - Q3 sales and margins surged, with net income and guidance both sharply improved.SMG
Q3 20242 Feb 2026 - All proposals passed and financial performance showed marked improvement.SMG
AGM 20262 Feb 2026 - Margin gains, innovation, and free cash flow drive a positive outlook despite topline shifts.SMG
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - 20% EBITDA growth, strong cash flow, and margin gains signal a robust turnaround.SMG
Q4 202416 Jan 2026 - Financial turnaround, board refreshment, and all proposals approved amid strong shareholder support.SMG
AGM 20259 Jan 2026 - Q1 sales and margin gains, U.S. Consumer up 11%, Hawthorne down 35%, outlook reaffirmed.SMG
Q1 20259 Jan 2026 - Proxy covers director elections, pay, auditor ratification, and incentive plan amendment.SMG
Proxy Filing17 Dec 2025